Analyst Ratings for Inovio Pharmaceuticals (INO) [Buys]
INO Rating Summary
INO Price Target Summary
- Highest: $4.00 (Oppenheimer)
- Lowest: $0.40 (Jefferies)
- Average: $1.80
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$1.80 (-81.8%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 48%
Avg. $ Target:
$1.80 (-81.8%)
* Over Last 12-Mos
Rating Score: 4.7 / 10
Percentile Rank: 48%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/25/2024 | Oppenheimer | Hartaj Singh | Upgrade | Outperform (Perform) |
4.00 (N/A) |
0.58 (9.91) |
1608.62% | Details |
| 1/4/2024 | JMP Securities | Roy Buchanan | New Coverage | Market Outperform (N/A) |
1.00 (N/A) |
0.56 (9.91) |
1669.64% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
